CSC picks up Porton's share of biopharm company

Computer Sciences Corp. acquired Porton International Inc.'s interest in biopharmaceutical company DynPort Vaccine Company LLC, for an undisclosed sum, the company said today.

Previously a join venture of CSC and biotechnology company Porton International, DVC of Frederick, Md., is part of CSC's enforcement, security and intelligence organization which CSC created two years ago to support programs that enhance U.S. security. DVC specializes in developing biodefense biological products and has been the prime systems contractor for the Defense Department's Joint Vaccine Acquisition Program since 1997.

Products in development at DVC include vaccines for botulism neurotoxin, tularemia, Venezuelan equine encephalitis, anthrax and plague. The company is also developing vaccinia immune globulin, a therapeutic blood product that will treat the complications of the smallpox vaccine.

CSC is a systems integrator headquartered in El Segundo, Calif. It is No. 3 on Washington Technology's 2004 Top 100 list of federal contractors, ranked according to their prime IT contracting revenue. The company employs approximately 90,000 workers and had revenue of $14.8 billion for the fiscal year ended April 2.

Reader Comments

Please post your comments here. Comments are moderated, so they may not appear immediately after submitting. We will not post comments that we consider abusive or off-topic.

Please type the letters/numbers you see above

What is your e-mail address?

My e-mail address is:

Do you have a password?

Forgot your password? Click here
close

Trending

  • Dive into our Contract Award database

    In an exclusive for WT Insider members, we are collecting all of the contract awards we cover into a database that you can sort by contractor, agency, value and other parameters. You can also download it into a spreadsheet. Our databases track awards back to 2013. Read More

  • Navigating the trends and issues of 2016 Nick Wakeman

    In our latest WT Insider Report, we pull together our best advice, insights and reporting on the trends and issues that will shape the market in 2016 and beyond. Read More

contracts DB

Washington Technology Daily

Sign up for our newsletter.

Terms and Privacy Policy consent

I agree to this site's Privacy Policy.